Rotarix Solution
Product Images NDC 58160-740

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Rotarix (NDC 58160-740). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glaxosmithkline Biologicals Sa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remove Vial Cap And Push Transfer Adapter Onto Vial (lyophilized Vaccine). (Rotarix Spl Graphic 01)

An illustration showing a transfer adapter positioned above a vial with an arrow indicating the adapter is to be attached to the vial. The image labels the components as 'Transfer adapter' and 'Vial.' This diagram likely demonstrates how to connect the adapter to the vial for administration or preparation purposes.*

FDA Label Image

Shake Diluent In Oral Applicator (white, Turbid Suspension). Connect Oral Applicator To Transfer Adapter. (Rotarix Spl Graphic 02)

An illustration showing the assembly of an oral applicator for vaccine administration. The diagram depicts the oral applicator being attached to or detached from a syringe, indicated by two black arrows pointing in opposite directions.*

FDA Label Image

Push Plunger Of Oral Applicator To Transfer Diluent Into Vial. Suspension Will Appear White And Turbid. (Rotarix Spl Graphic 03)

An instructional illustration showing an oral syringe with a capped tip and an arrow indicating to remove the cap. The syringe appears to be intended for oral administration of medication or vaccine solution.*

FDA Label Image

Withdraw Vaccine Into Oral Applicator. (Rotarix Spl Graphic 04)

An instructional diagram showing a pre-filled oral syringe for Rotarix (Rotavirus Vaccine, Live, Oral) with a protective cap and a downward pointing arrow, indicating a step in the preparation or administration process for the vaccine solution.*

FDA Label Image

Twist And Remove The Oral Applicator. (Rotarix Spl Graphic 05)

Illustration showing how to prepare an oral vaccine syringe by twisting or rotating the cap to remove it before administration. The syringe contains a clear solution and is designed for oral use.*

FDA Label Image

Ready For Oral Administration. (Rotarix Spl Graphic 06)

Illustration showing an infant receiving an oral vaccine dose using a dropper. The dropper is held by an adult hand and positioned near the infant's mouth for administration of the solution.*

FDA Label Image

Do Not Use A Needle With Rotarix. Not For Injection. (Rotarix Spl Graphic 07)

Illustration of a syringe with a needle crossed out by a large X mark, indicating that the Rotarix rotavirus vaccine, which is an oral solution, should not be administered via injection.*

FDA Label Image

Figure 1. Administration Of Rotarix (Rotarix Spl Graphic 08)

An illustration showing administration of an oral medication to an infant using a dropper, depicting the dose being given into the baby's mouth.*

FDA Label Image

Rotarix Carton (Rotarix Spl Graphic 09)

Label of Rotarix Rotavirus Vaccine, Live, Oral solution by GlaxoSmithKline Biologicals SA. Highlights oral use only with a warning not to inject. Indicated for use from 6 to 24 weeks of age. Includes contents listing 10 vials of lyophilized vaccine, 10 prefilled oral dosing applicators of diluent, and 10 transfer adapters for reconstitution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.